Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by SouthernTierTomon Feb 13, 2021 11:04am
268 Views
Post# 32561577

The journey to FDA success is a long and arduous one....

The journey to FDA success is a long and arduous one....Remember people...as an experienced BIO-invester I would remind "peeps" to remain even keeled on the journey that is now phase 2.

The ramp-up of US sites albeit "exciting" will require funding AND if it is as gouda as we think-ah it could be....it will be funded buy those closest to the "inner-circle"

I always question any company with "Big-Hitters" on the team...why attempt to fund a firm at elevated prices in the "public-domain" when the end result is "likely to please"?

I'm long this, but only a little, until we see more $$ brought in to the "coughers" to fund the US FDA initiative......

Let's not forget that "yard sales seldom see home-owners knowingly give up things of value to strangers" ( STD - circa 2020 )

Bon appetito...curious to watch the next leg of the bullboared tale

T
<< Previous
Bullboard Posts
Next >>